Replimune Appoints Former Sanofi U.S. Commercial Oncology
WOBURN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development...
Source: globenewswire.com
Stay updated with breaking news from Pharma Strategy Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WOBURN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development...